The global genomics market reached a strong growth in 2020. Looking forward, the market is expected to grow at a CAGR of around 16% during 2021-2026, according to the latest report by IMARC Group.
Genomics refers to the study of the function, structure, and inheritance of the genome of an organism. It addresses the intrarelationship of all genes for identifying their combined influence on the overall development. It involves several systems, consumables, software and services for the diagnosis, drug discovery, and development of precision medicine. Some of the technologies utilized for genomics include nucleic acid extraction, polymerase chain reaction (PCR) and single-cell genomics analysis.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request Free Sample Report:
The increasing prevalence of chronic diseases represents one of the key factors strengthening the growth of the market. Besides this, genomic data is widely used to produce targeted and personalized medicines and study the growth of military genomics across clinical workflows. This, in confluence with an increasing utilization of genetically modified (GM) plants and organisms in the agriculture sector, is propelling the market growth. Furthermore, technological advancements like the introduction of genomics-based tests and apps and extensive research and development (R&D) activities in the field of bioinformatics are also supporting the market growth.
Ask Analyst and Browse Full Report with TOC & List of Figure: https://bit.ly/2LnYx4T
Breakup by Component:
- Instruments and Software
- Consumables and Reagents
- Core Genomics Services
- NGS-Based Services
- Biomarker Translation Services
- Computational Services
Breakup by Application:
- Functional Genomics
- Biomarkers Discovery
- Pathway Analysis
Breakup by Technology:
- Polymerase Chain Reaction
- Nucleic Acid Extraction and Purification
Breakup by End-User:
- Research Centers
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
Breakup by Geography:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East & Africa
The report has also analysed the competitive landscape of the market with some of the key players being 23andMe Inc., Agilent Technologies Inc., Bayer Aktiengesellschaft, BGI Genomics Co. Ltd., Bio-RAD Laboratories Inc., Danaher Corporation, Illumina Inc., Oxford Nanopore Technologies, PerkinElmer Inc., Myriad Genetics Inc., Roche Holding AG, Thermo Fisher Scientific Inc., etc.
Key highlights of the report:
- Market Performance (2015-2020)
- Market Outlook (2021- 2026)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800